The way you draw a spiral can flag Parkinson’s with up to 99% accuracy

Researchers reported in late August 2026 that analyzing how a person draws a simple spiral on paper can help identify Parkinson’s disease with striking accuracy, offering a potential low-cost screening tool that requires nothing more than a pen, paper, and a way to digitally analyze the resulting drawing. The approach builds on decades of clinical observation that Parkinson’s disease alters fine motor control in ways that show up clearly in handwriting and drawing tasks.

How the Drawing Test Works

The test asks participants to trace or freehand draw an Archimedean spiral, a simple looping shape that has long been used informally by neurologists as a quick bedside check for tremor and motor control issues. What has changed is the level of analysis applied to the resulting drawing: rather than a clinician simply eyeballing the spiral for obvious shakiness, researchers digitize the drawing and run detailed computational analysis on subtle variations in line pressure, speed, spacing, and tremor frequency that would be difficult or impossible for the human eye to catch reliably.

That combination of a decades-old bedside test with modern signal-processing techniques is what has pushed diagnostic accuracy dramatically higher than earlier, simpler scoring methods based on visual inspection alone. By capturing fine-grained data about exactly how the pen moves across the page, the analysis can pick up on movement irregularities that emerge early in the disease process, sometimes before they would be obvious enough for a doctor to notice during a routine visual exam.

What the Study Found

The researchers behind the study reported that their drawing-based analysis could distinguish people with Parkinson’s disease from those without it with accuracy reaching as high as 99% in their testing, a figure well above what earlier handwriting- and drawing-based screening approaches have typically achieved. That level of accuracy places the spiral-drawing analysis in the same conversation as far more expensive and invasive diagnostic tools, at least in terms of its ability to correctly classify test subjects.

Why Movement Changes Show Up in Handwriting

Parkinson’s disease results from the progressive loss of dopamine-producing neurons in a region of the brain that helps coordinate smooth, controlled movement. As those neurons decline, patients typically develop a resting tremor, muscle rigidity, and bradykinesia, a slowing and shrinking of voluntary movements that shows up in everyday tasks ranging from walking to buttoning a shirt to handwriting.

That connection between dopamine loss and fine motor control is why handwriting analysis has been a recognized, if historically imprecise, diagnostic clue for Parkinson’s disease for a long time. Micrographia, a condition in which handwriting becomes progressively smaller and more cramped, is a well-documented early sign of the disease, and the same underlying motor deficits that shrink handwriting also disrupt the smooth, evenly spaced loops needed to draw a clean spiral, which is precisely the kind of subtle distortion the new computational analysis is designed to detect.

What This Could Mean for Early Diagnosis

Parkinson’s disease is notoriously difficult to diagnose in its earliest stages, since there is no single definitive lab test and doctors typically rely on clinical observation of symptoms that may not become obvious until significant neurological damage has already occurred. A cheap, fast, non-invasive screening tool based on something as simple as drawing a spiral could help identify at-risk patients earlier, potentially opening the door to earlier treatment and monitoring before symptoms progress further.

Researchers caution that a screening tool, however accurate in a study setting, is not the same as a full clinical diagnosis, and further validation across larger and more diverse patient populations would likely be needed before such a test could be deployed widely in doctors’ offices or as a home screening option. Still, the accuracy reported in this study adds to a growing wave of interest in using accessible, low-tech data like handwriting alongside more advanced computational analysis to catch neurological disease earlier than traditional clinical exams typically allow.

Other Movement-Based Screening Tools

Spiral drawing is part of a broader family of movement-based screening approaches researchers have explored for Parkinson’s disease, including gait analysis that tracks walking speed and stride length, voice recordings that pick up on subtle changes in speech rhythm and volume, and typing-pattern analysis that measures the timing between keystrokes on a computer or phone. Each of these approaches taps into a different observable consequence of the same underlying motor-control breakdown, giving researchers multiple potential angles for building affordable, non-invasive screening tools.

What makes drawing-based analysis particularly appealing compared with some of these alternatives is its simplicity and low cost: it requires no specialized sensors or wearable hardware, just a writing surface and software capable of digitizing and analyzing the resulting image or stroke data. That low barrier to entry is part of why researchers see potential for the approach to be deployed widely, including in settings like primary-care offices or community health screenings that lack access to specialized neurology equipment.

Existing Diagnostic Methods for Parkinson’s Disease

Currently, a Parkinson’s diagnosis typically rests on a clinical neurological examination, in which a doctor assesses a patient for the disease’s hallmark motor symptoms, sometimes supported by imaging techniques that can visualize dopamine activity in the brain. These imaging approaches tend to be expensive and are not always readily available outside of larger medical centers, which is part of why doctors often rely primarily on clinical judgment and symptom history when making an initial diagnosis.

Because there is no single blood test or simple lab panel that can definitively confirm Parkinson’s disease on its own, diagnosis can sometimes take months or longer as doctors track how a patient’s symptoms evolve over time and rule out other conditions with similar presentations, such as essential tremor or certain drug side effects. A reliable, low-cost screening tool that could flag likely cases earlier in that process could help direct patients toward specialist evaluation sooner, rather than waiting for symptoms to become unambiguous enough for a confident clinical diagnosis.

This article was produced with the assistance of AI and reviewed by Morning Overview editors.

More from Morning Overview